Aon, Willis Towers Watson To Sell WTW Assets To Gallagher For $3.57 Bln

Aon plc (AON) and Willis Towers Watson (WLTW) Wednesday said they signed a definitive agreement to sell Willis Re and a set of Willis Towers Watson corporate risk and broking and health and benefits services to Arthur J. Gallagher & Co. for a total consideration of $3.57 billion. Gallagher is an insurance, risk management, and consulting services company headquartered in Rolling Meadows in Illinois.

The pending combination with Willis Towers Watson is expected to deliver revenue growth, margin expansion through the delivery of better solutions, increased cash flow and earnings growth, and a strong balance sheet, to generate attractive returns for shareholders in the future.

Aon said it remains committed to $800 million of cost synergies through the combination.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
Follow RTT